Home ›
Organizations ›
FOUNDATION FOR THE ACCREDITATION OF CELLULAR THERAPY
FOUNDATION FOR THE ACCREDITATION OF CELLULAR THERAPY
NE · Medical Research · EIN 841363353
7
Executives Disclosed
$7.2M
Annual Revenue
$3.8M
Total Assets
1.5:1
Internal Pay Ratio
FOUNDATION FOR THE ACCREDITATION OF CELLULAR THERAPY has 7 executives with disclosed compensation. The highest-paid executive, Phyllis Warkentin Md (CHIEF MED OFFICER), received peak total compensation of $347,558. The sector average for Medical Research executives is $311K.
Top Executive Compensation Over Time
Executive Compensation
| Name | Title | Peak Comp. | Latest Comp. | Years | vs. Household |
|---|---|---|---|---|---|
| Phyllis Warkentin | CHIEF MED OFFICER | $348K | $348K | 2022–2024 | 4.6x |
| Joseph Schwartz | SENIOR MEDICAL OFFICER | $263K | $263K | 2024–2024 | 3.5x |
| David Schmahl | CHIEF EXEC OFFICER | $238K | $238K | 2024–2024 | 3.2x |
| Linda Miller Mpa | CHIEF OPER OFFICER | $238K | $238K | 2016–2024 | 3.2x |
| Alisa Forsythe | DIRECTOR OF TECHNOLOGY SER | $131K | $0 | 2023–2024 | 1.7x |
| Meredith Lambe | DIRECTOR OF FUND DEVELOPMENT | $126K | $0 | 2023–2023 | 1.7x |
| Kara Wacker | STRATEGIC PLANNING ADMINISTRATOR | $102K | $0 | 2022–2022 | 1.4x |
Annual Summary
| Year | Executives | Avg. Comp. | Highest Comp. | Total Payroll |
|---|---|---|---|---|
| 2016 | 1 | $0 | $0 | $0 |
| 2017 | 1 | $0 | $0 | $0 |
| 2018 | 1 | $0 | $0 | $0 |
| 2022 | 3 | $264K | $320K | $528K |
| 2023 | 4 | $276K | $333K | $553K |
| 2024 | 5 | $272K | $348K | $1.1M |
Email Alerts
Get notified about FOUNDATION FOR THE ACCREDITATION OF CELLULAR THERAPY
Get an email when a new IRS Form 990 filing is posted that includes this organization. We send a confirmation link first - we don't add you to any other list.